Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 886982 NEW YORK, NY
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$65,276,908
+$30,600,192 QoQ
Shares Held
2,580,115
+65.6% QoQ
Ownership
1.50%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 1% None 1%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Derivatives in ACAD

reported options exposure · as of Sep 30, 2025
CallValue
$1,916,332
CallShares
89,800
PutValue
$1,916,332
PutShares
89,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. ACAD ranks #54 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in ACAD

Export CSV
45 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $65,276,908 2,580,115
2026-03-31 $34,676,716 1,557,804
2025-12-31 $41,936,061 1,570,051
2025-09-30 $1,916,332 89,800
2025-09-30 $44,866,282 2,102,450
2025-09-30 $1,916,332 89,800
2025-06-30 $1,936,986 89,800
2025-06-30 $1,936,986 89,800
2025-06-30 $31,675,285 1,468,488
2025-03-31 $1,491,578 89,800
2025-03-31 $36,189,368 2,178,770
2025-03-31 $1,491,578 89,800
2024-12-31 $1,649,665 89,900
2024-12-31 $1,647,830 89,800
2024-12-31 $52,856,513 2,880,464
2024-09-30 $1,382,662 89,900
2024-09-30 $27,051,250 1,758,859
2024-09-30 $1,381,124 89,800
2024-06-30 $1,460,875 89,900
2024-06-30 $1,459,250 89,800
2024-06-30 $21,790,339 1,340,944
2024-03-31 $13,458,961 727,905
2023-12-31 $25,178,562 804,170
2023-12-31 $1,443,391 46,100
2023-09-30 $14,976,144 718,625
2023-06-30 $30,498,504 1,273,424
2023-03-31 $18,438,668 979,738
2022-12-31 $15,770,717 990,623
2022-09-30 $19,311,310 1,180,398
2022-06-30 $14,900,090 1,057,494
2022-03-31 $26,748,010 1,104,377
2021-12-31 $27,586,082 1,181,923
2021-09-30 $13,733,911 826,846
2021-06-30 $13,690,471 561,315
2021-03-31 $26,890,024 1,042,249
2020-12-31 $54,052,870 1,011,090
2020-12-31 $213,840 4,000
2020-09-30 $39,602,763 960,067
2020-09-30 $1,402,500 34,000
2020-09-30 $1,315,875 31,900
2020-06-30 $53,343,464 1,100,546
2020-06-30 $969,400 20,000
2020-06-30 $1,163,280 24,000
2020-03-31 $3,147,625 74,500
2020-03-31 $59,001,153 1,396,477